A series of mutations in open reading frame (ORF) E5 of bovine papillomavirus type 1 has been constructed to determine whether this putative gene is required for in vitro oncogenic transformation by viral DNA. Frameshift mutations at either of two different positions located exclusively in ORF E5 cause a substantial reduction in the ability ofthe cloned viral DNA to induce the appearance of transformed foci of mouse C127 cells. A genetic mapping experiment with one of the mutants indicates that this characteristic transformation defect is actually due to the constructed mutation in ORF E5. Analysis of 10 different mutants with sequence changes at a single position in the ORF showed that there is an exact correspondence between transformation-competence and the ability of the 3' half of ORF E5 to be correctly translated. The transformation defect of an ORF E5 frameshift mutant can be suppressed by a second mutation that restores the correct reading frame to most of the ORF, but not by one that restores the reading frame near the 3' end of the ORF. These results constitute strong genetic evidence that translation of ORF E5 is required for efficient transformation of mouse C127 cells by bovine papillomavirus DNA. Wild-type ORF E5 has the potential to encode a short hydrophobic protein or polypeptide domain.
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The papillomaviruses cause benign epithelial-cell tumors in infected animals and humans, and these lesions occasionally progress to malignancy (1, 2) . Infection by a subset of the papillomaviruses, the fibropapillomaviruses, induces fibroblastic as well as epithelial proliferation (1) . This property of the fibropapillomaviruses is reflected in their potent transforming activity toward fibroblasts in culture. The study of in vitro transformation by these viruses may shed light on their biological activity during natural infection as well as on the mechanism of oncogenic transformation.
The best-studied fibropapillomavirus is bovine papillomavirus type 1 (BPV), which efficiently induces the appearance of foci of morphologically transformed mouse cells in vitro (3, 4) . The 7945-base-pair (bp) BPV genome contains a number of translational open reading frames (ORFs) that are thought to encode viral proteins (5, 6) (Fig. la) . A 5437-bp subgenomic transforming fragment of viral DNA contains eight ORFs which have been designated El through E8 (5-7). All the ORFs are located on the same strand of the viral DNA and each ORF overlaps with at least one other. This complex genetic organization has prevented the precise definition of the papillomavirus transforming genes. Moreover, the assignment of specific proteins to individual ORFs has been hampered by the difficulty of identifying nonstructural viral proteins in infected or transformed cells, but recently a likely candidate for a protein product of ORF E6 has been detected in BPV-transformed mouse C127 cells (8 
MATERIALS AND METHODS
General Methods. The starting plasmids for these experiments were pBPV-142-6, which consists of the full-length BPV genome inserted into pML2d (18) , and pBPV-Hll, which consists of the 5437-bp HindIII-BamHI transforming segment of BPV DNA inserted into pBRd (19) . Restriction endonucleases and other DNA-modifying enzymes were purchased from commercial sources and used according to the suppliers' instructions. After the in vitro manipulations outlined below, bacterial transformations were carried out in Escherichia coli strain DH-1 according to Hanahan (20) , and ampicillin-resistant bacterial colonies were screened for mutant DNA by restriction analysis of small-scale DNA preparations (21) .
BstXl Mutations. One microgram of BstXI-digested pBPV-142-6 DNA was treated with 60 units of nuclease S1 for 10 min at 20°C, ligated at low DNA concentration with T4 DNA Abbreviations: BPV, bovine papillomavirus; ORF, open reading frame; bp, base pair(s). ligase, and digested with BstXI. After bacterial transformation, mutants pE5DB-4, -6, and -13 were isolated.
Synthetic Xho I linkers were inserted into BstXI-treated DNA as described (14) to generate pE5XL-1. pE5XL-2 was derived from pE5XL-1 DNA by complete digestion with Xho I and ligation at low DNA concentration. After Xho Idigested pE5XL-l DNA was treated with nuclease S1, ligated, and redigested with Xho I, mutant pE5DX-10 was recovered. Mutant pESDX-10 contains a deletion in the pML2d segment of the plasmid in addition to the mutation at the BstXI site, but this second extraneous mutation was separated from the viral DNA sequences prior to assay for biological activity.
pE5DX-8 was constructed by treating Xho I-digested pESXL-2 with nuclease S1, ligase, and Xho I. pE5DX-16 was constructed by digesting pESXL-2 DNA with Xho I, filling in the ends of the DNA molecule by incubation with the Klenow fragment of DNA polymerase I plus all four deoxyribonucleoside triphosphates, ligation, and redigestion with Xho I. pE5DX-17 was constructed by treating Xho I-digested, polymerase-repaired pE5XL-2 DNA with nuclease S1, followed by ligation and redigestion with Xho I. pE5DX-18 was constructed by treating Xho I-digested pE5XL-2 DNA with the Klenow fragment of DNA polymerase I plus dCTP, dGTP, and dTTP, followed by digestion with nuclease S1, ligation, and Xho I digestion.
Spe I Mutations and Genetic Mapping. pBPV-H11 was digested to completion with Spe I. The linear DNA was digested with nuclease S1, ligated, and redigested with Spe I. pE5HS-9 was isolated following bacterial transformation. pE5HS-9 and pBPV-142-6 were digested to completion with BstXI and Sal I (the latter enzyme cleaves in the bacterial vector segment 275 bp from the BamHI site at the junction with viral DNA). The two DNAs were ligated at equimolar concentration (total DNA concentration 30 ,g/ml) and used to transform bacteria. A plasmid the size of pE5HS-9 containing the wild-type DNA segment downstream of the BstXI site identified by the presence of the Spe I site and designated pE59MR-2. Double Mutations. pXLBR-1 was constructed by inserting the HindIII-BamHI segment ofpE5XL-2 into pBRd. pE5XS-1 was constructed by sequentially treating pXLBR-1 with Spe I, nuclease S1, T4 DNA ligase, and Spe I. pXLBR-1 was also partially digested with Acc I in the presence of ethidium bromide at 5 ,ug/ml. Full-length linear partial digestion products were purified by agarose gel electrophoresis, treated with the Klenow fragment of DNA polymerase plus dATP and dTTP, and treated with T4 DNA ligase. pE5XA-1 was identified by restriction analysis.
Nucleotide Sequencing. The nucleotide sequences of all the mutations described in this report were determined by the method of Maxam and Gilbert (22) (23) . After a 12-hr incubation with the DNA, the cells were subjected to a 20% (vol/vol) dimethyl sulfoxide shock and then incubated for 12 hr at 37°C in the presence of 5 mM sodium butyrate (24) . The cells were then passaged 1:3 and incubated at 37°C with medium changes twice weekly. Foci were counted between 14 and 18 days after DNA transfer. Table 1 . All seven mutants with out-of-frame mutations in ORF E5 exhibited a severe transformation defect. Two independent DNA preparations were tested for each defective mutant, and in several cases, multiple independent isolates containing the same mutations were tested and displayed identical defects. Moreover, an independent isolate of pE5XL-2 displayed a similar focusforming defect when assayed by our standard procedure or when the viral DNA was not separated from bacterial plasmid sequences prior to DNA transfer and the dimethyl sulfoxide and sodium butyrate treatments were omitted (J.T.S., data not shown). In contrast, the three mutants with in-frame mutations (pE5XL-1, pESDX-8, and pE5DX-18) induced transformed foci as efficiently as did the wild-type viral genome. The foci induced by wild-type viral DNA and these mutants became visible the same number of days after DNA transfer, they enlarged at the same rate, and there were no obvious differences visible by phase-contrast microscopy.
Mutations at the Spe I site in ORF E5 also caused a transformation defect. These mutations were constructed in pBPV-H11, a plasmid that contains the 5437-bp subgenomic transforming fragment ofthe viral genome. (This plasmid was used in these experiments to facilitate mutant construction because the nontransforming segment of the viral DNA contains a second Spe I site.) Two independent mutants were identified by the loss of the Spe I site, and sequence analysis showed that both contained the same 4-bp deletion at the Spe I site (see legend to Fig. 3 ). When wild-type and mutant viral DNA were separated from the prokaryotic vector sequences and added to mouse C127 cells, both independent mutants were far less efficient than wild-type at inducing the formation of foci (Fig. 3 shows the results for one of the isolates, pE5HS-9).
A genetic mapping experiment was performed on the Spe I mutant pESHS-9 to prove that the defect in transformation was caused by the constructed mutation in ORF E5. A DNA fragment, containing the 562-bp segment of wild-type viral DNA from the BstXI site in ORF E5 to the 3' end of the transforming segment, was substituted for the corresponding mutant DNA segment. This substitution restored efficient focus-forming activity to the reconstructed genome (pE59MR-2), which now contained a wild-type E5 region (Fig. 3) . The fragment that was substituted in this experiment contains ORF E5 but no other viral ORF expressed in transformed cells; thus, the transformation defect displayed by the viral DNA with the mutation in ORF E5 is not caused by an undetected mutation in another ORF.
These results suggested that ORF E5 has to be translated to allow efficient focus formation in our transformation assay. To examine this hypothesis in more detail, we con- structed two double mutants, each of whch combined the 4-bp insertion of pESXL-2 and a second mutation downstream in ORF E5. Sequence analysis demonstrated that the region between the two mutations is out-of-frame in both mutants (but it does not contain any stop codons); the correct reading frame is restored downstream of the second mutation (Fig. 4) . For pESXS-1, the second mutation is the same 4-bp deletion at the Spe I site as is present in pESHS-9; thus three-fourths of ORF E5 downstream of the first ATG is in-frame. As shown in Fig. 4 , pESXS-1 with mutations at both the BstXI and Spe I sites efficiently transforms cells even though either mutation by itself causes a severe transformation defect. For pESXA-1, the downstream mutation that restores the correct reading frame is a 2-bp insertion at the Acc I site near the 3' end of ORF E5; less than one-third of ORF E5 is in-frame. Several independent isolates of this mutant display a marked transformation defect. Efficient focus formation was restored when the Xho I-BamHI fragment of pESXA-1 was replaced by the corresponding fragment of pESXS-1 (data not shown).
DISCUSSION
These experiments examine the requirement of BPV ORF E5 for efficient transformation of mouse C127 cells. Mutations at two different positions located exclusively in this ORF characteristically cause a substantial drop in focus-forming activity in these cells, thus confirming the previously reported effect of mutations in ORF E5 (15) (16) (17) . Further, the results strongly suggest that the transformation defect of the mutants is due to the inability of ORF E5 to be translated and not to an unanticipated effect of the mutation on some other ORF.
The genetic mapping experiment with the Spe I mutant indicates that the transformation defect is likely to be due to Plasmid pBPV-HII pE5XLBR-I pE5HS-9 pE5XS-I pE5XA-I1 the constructed mutation in ORF E5. Although a formal genetic mapping experiment has not been performed with the defective mutants with sequence changes at the BstXI site, several observations indicate that the transformation defect is actually due to the constructed mutations. Numerous different mutants with out-of-frame mutations at this site are defective; and in several cases, more than one independent isolate of the same defective mutant has been assayed. Moreover, in two cases, in-frame transformation-competent mutants (pE5DX-8, pE5DX-18) were derived from a defective out-of-frame one (pE5XL-2) by further sequence changes at the site of the original mutation.
The correlation between the ability of ORF E5 to be translated and of the viral mutants to transform C127 cells suggests that translation of this ORF is required for efficient focus formation by linear BPV DNA. The most likely basis for this requirement is that ORF E5 encodes a protein sequence essential for transformation. This interpretation is strengthened by the contrasting transforming activities of the two double mutants. Both mutants contain the same 4-bp insertion near the 5' end of ORF E5, which causes a shift in reading frame. The mutants differ in the position of the downstream mutation and hence in the position at which the correct reading frame is restored. pE5XS-1, in which most of ORF E5 can be translated in the correct frame, transforms efficiently; pESXA-1, in which most of the ORF is in the incorrect frame, is transformation-defective. Thus, translation of ORF E5 in the correct reading frame and not merely translation of this region of RNA seems to be required for transformation. However, this requirement is not absolute. In numerous transformation experiments with BamHI-digested full-length viral DNA, the out-of-frame BstXI mutants invariably displayed a marked quantitative defect in focus (Fig. 5) . Although some of the in-frame mutations may cause defects in other viral activities, the focus-forming activity of ORF E5 in C127 cells is not impaired by mutations that would result in amino acid substitutions near the first methionine. The portion of ORF E5 downstream of the Spe I site, on the other hand, seems essential for efficient focus formation. The predicted amino acid sequence for this portion of the ORF contains an uninterrupted stretch of hydrophobic residues (Fig. 5) , a sequence that suggests membrane association. The corresponding region of the two other sequenced genomes of fibropapillomaviruses, those of bovine papillomavirus type 2 and the deer fibromavirus, have the potential to encode a short polypeptide of similar composition (ref. 16 and W. Lancaster, personal communication).
Translation of ORF E5 from the AUG just 5' of the BstXI site would result in the production of a 44 amino acid hydrophobic polypeptide. This AUG is not the most 5' one in any characterized BPV message (25, 26) , and it is not known whether translation of ORF E5 initiates at this codon or whether the ORF E5 polypeptide is a domain of a larger protein initiated upstream. If the latter is the case, ORF E5 may encode a C-terminal hydrophobic domain that causes the larger protein to be membrane-associated. Such a protein could be translated from an as-yet-undetected spliced mRNA or it could be synthesized via frameshift suppression of the termination codon at the 3' end of ORF E2. However, it does not appear that upstream sequences are absolutely required for the transforming activity of ORF E5 in some plasmid constructions (15) . Biochemical identification and characterization of the ORF E5 gene product are obviously required to determine its structure and localization. The availability of the mutations that cause predictable alterations in the amino acid sequence of the ORF E5 protein should facilitate this analysis. Moreover, the mutants described here should be a useful reference set for determining the requirement for BPV ORF E5 in other biological activities of the viral DNA.
